Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yago Nieto

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
Haematologica|February 27, 2003
The verdict is not in yet. Analysis of the randomized trials of high-dose chemotherapy for breast cancerYago Nieto
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
DNA-binding agentsYago Nieto
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
DNA-binding agentsYago Nieto
Current Oncology Reports|March 16, 2013
Transplantation for refractory germ cell tumors: does it really make a difference?Yago Nieto
Immunotherapy|June 19, 2026
Recent advances in bispecific natural killer cell engagers for cancer immunotherapyMousa Thalji, Yago Nieto
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2025
Harnessing engineered NK cells for refractory CD30+ lymphomaYago Nieto, Katayoun Rezvani
Human Vaccines & Immunotherapeutics|June 17, 2026
NK cell-based immunotherapyMark Alexander Forsberg, Yago Nieto
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
DNA-binding agentsYago Nieto, Roy B Jones
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2011
High-dose chemotherapy with autologous stem cell transplant for breast cancer: what have we learned 25 years later?Yago Nieto, Elizabeth J Shpall
Current Opinion in Oncology|June 18, 2009
High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?Yago Nieto, Elizabeth J Shpall
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
Haematologica|February 27, 2003
The verdict is not in yet. Analysis of the randomized trials of high-dose chemotherapy for breast cancerYago Nieto
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
DNA-binding agentsYago Nieto
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
DNA-binding agentsYago Nieto
Current Oncology Reports|March 16, 2013
Transplantation for refractory germ cell tumors: does it really make a difference?Yago Nieto
Immunotherapy|June 19, 2026
Recent advances in bispecific natural killer cell engagers for cancer immunotherapyMousa Thalji, Yago Nieto
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2025
Harnessing engineered NK cells for refractory CD30+ lymphomaYago Nieto, Katayoun Rezvani
Human Vaccines & Immunotherapeutics|June 17, 2026
NK cell-based immunotherapyMark Alexander Forsberg, Yago Nieto
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
DNA-binding agentsYago Nieto, Roy B Jones
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2011
High-dose chemotherapy with autologous stem cell transplant for breast cancer: what have we learned 25 years later?Yago Nieto, Elizabeth J Shpall
Current Opinion in Oncology|June 18, 2009
High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?Yago Nieto, Elizabeth J Shpall
Pageof 25